MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
GAITHERSBURG: MaxCyte Inc., (LSE: MXCT, MXCN), a leading provider of platform technologies for cell engineering, today announced the commencement of an underwritten offering of 12,000,000 shares of common stock at…